Elsayed S. Moubarak: Evaluating Established and Emerging Biomarkers in Hemophilia A and B Management
Elsayed S. Moubarak, Member of NEGIDA Corporation, Researcher at Research Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m pleased to share that our recent review article has been published in ASIDE Internal Medicine.
In this narrative review, we explored established and emerging biomarkers in Hemophilia A and B, highlighting their diagnostic, prognostic, and therapeutic implications in the era of extended half-life therapies, non-factor treatments, and gene therapy.
The review discusses:
- FVIII/FIX activity assays and inhibitor testing
- Genotyping approaches
- Global hemostasis assays
- Pharmacokinetic-guided prophylaxis
- Novel inflammatory and angiogenic markers linked to arthropathy
I am honored to contribute as Second Author and Corresponding Author on this work.
Grateful to my co-authors for their collaboration and dedication.”
Title: Biomarkers in Hemophilia: Diagnostic, Prognostic, and Treatment-Selection Utility: A Narrative Review of the Literature
Authors: Dalia Atef Abouda, Elsayed S. Moubarak, Fatma ElBadrawy, Malak A. Hassan, Mohamed Mohsen Helal, Abdallah M. Ibrahim, Hassan H. Eladl, Mohammad Mahadin, Mohamed Elsaid
Read the Full Article on ASIDE Internal Medicine Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 20, 2026, 13:06Bastian Volbers: ESO and SESAM Sign Landmark Affiliation Agreement at SESAM 2026
-
Jun 20, 2026, 12:56Yusra Junaid: Two New Publications in Thrombosis and Cancer Research
-
Jun 20, 2026, 12:39Mayka Sanchez: Updates from EFAPH 2026 Meeting
-
Jun 20, 2026, 12:22Karen Fahey: A More Inclusive Future for the Bleeding Disorders Community
-
Jun 20, 2026, 10:48Alliah Czarielle Formalejo: Loving People Without Defining Them
-
Jun 20, 2026, 10:18Luciano Martelotto: CD200R1, IL-17A, and the Future of Cancer Thrombosis Prevention
-
Jun 20, 2026, 10:09Nicolle Davis: Celebrating the Team Behind Life-Saving Mobile Stroke Care
-
Jun 20, 2026, 07:09Norio Nakatsuji: LRP5 Inhibition Shows Promise for Safer Blood-Thinning Strategies
-
Jun 20, 2026, 07:02Sex Hormone Influences on Venous Thrombosis in Episode 32 of CLOT Conversations – Thrombosis Canada